Intracranial venous malformations are abnormally enlarged veins in brain. Venous malformations are a type of blood vessel abnormality in the brain or spinal cord.
The chance of a brain AVM bleeding is 1 percent to 3 percent per year. Over 15 years, the total chance of an AVM bleeding into the brain — causing brain damage and stroke — is 25 percent.The risk of recurrent intracranial bleeding is slightly higher for a short time after the first bleed. In two studies, the risk during the first year after initial bleeding was 6 percent and then dropped to the baseline rate. In another study, the risk of recurrence during the first year was 17.9 percent. The risk of recurrent bleeding may be even higher in the first year after the second bleed and has been reported to be 25 percent during that year. People who are between 11 to 35 years old and who have an AVM are at a slightly higher risk of bleeding.
The most important goal AVM treatment is to prevent internal bleeding from rupture, because which can lead to stroke / death. However, seizure control or stabilization of progressive neurological deficits are occasionally treatment goals. Though medication may be prescribed, it does not cure AVMs but medications are used to control pain and seizures. The management options for brain AVMs include observation or various treatment techniques, such as endovascular embolization, microsurgical techniques and stereotactic radiotherapy used alone or in combination with varying degrees of treatment-associated morbidity and mortality.